Allogene Therapeutics(ALLO) - 2023 Q4 - Earnings Call Transcript

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2023 Earnings Call Transcript March 14, 2024 5:00 PM ET Company Participants Christine Cassiano - Chief Corporate Affairs and Brand Strategy Officer David Chang - President and Chief Executive Officer Zachary Roberts - Executive Vice President of Research and Development and Chief Medical Officer Geoff Parker - Chief financial officer Conference Call Participants Tyler Van Buren - TD Cowen Salveen Richter - Goldman Sachs Brian Cheng - JPMorgan Jack Allen - Baird ...